Tilray Brands, Inc. Proceeds from Long-Term Debt Issued
Tilray Brands, Inc. (TLRY) reported Proceeds from Long-Term Debt Issued of $0 for the 9-month period ending 2026-02-28, per its 10-Q filed 2026-04-01.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2026-04-01
- 2026-02-28: Proceeds from Issuance of Long-term Debt 9 month $0.00.
- 2025-02-28: Proceeds from Issuance of Long-term Debt 9 month $3.45M.
| Period end | Proceeds from Issuance of Long-term Debt 9 month |
|---|---|
| 2026-02-28 | $0.00 10-Q · filed 2026-04-01 |
| 2025-02-28 | $3.45M 10-Q · filed 2026-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |